SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-173840
Filing Date
2019-06-14
Accepted
2019-06-14 17:26:01
Documents
1
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FINANCIAL INVESTMENT CAYMAN LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d767108dsc13d.htm SC 13D 101415
  Complete submission text file 0001193125-19-173840.txt   103074
Mailing Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-89732 | Film No.: 19899841
SIC: 2834 Pharmaceutical Preparations